Log In
BCIQ
Print this Print this
 

rhIL-11

  Manage Alerts
Collapse Summary General Information
Company Uni-Bio Science Group Ltd.
DescriptionRecombinant human interleukin-11 (IL-11)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationThrombocytopenia
Indication DetailsTreat chemotherapy-induced thrombocytopenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today